Day 2 of the European Committee for Treatment and Research of Multiple Sclerosis Congress

Exciting stem cell trial results, progressive multiple sclerosis (MS), clinical trials, comorbidities and the treatment of symptoms were some of the key topics explored on Day 2 of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) Congress, being held in Stockholm, Sweden. The co-founder and chief science communicator, Brett Drummond, and MStranslate guest reporter, Dr Travis Stiles (CEO, Novoron Bioscience) sat down at the end of the day to reflect on, and discuss, these presentations in more detail.

Learn more about ECTRIMS Congress here: ectrims-congress.eu/2019